EVALUATING IN VIVO MODELS IN PRECLINICAL DRUG DEVELOPMENT

In vivo models are essential tools for preclinical drug development, facilitating researchers to determine the efficacy and safety of novel drugs in a living organism. Choosing the appropriate species is crucial to confirm meaningful preclinical findings. This demands a meticulous understanding of the disease being studied, as well as the constrain